GT

Guncha Tabasum

Active Director Director DIN 06506988
DIN 06506988 First appointment Apr 2013 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2013
Shareholding value •••• Premium profile

About Guncha Tabasum

Data last updated:

Guncha Tabasum is a Director at Ezak Pharma Private Limited (since 2013). The company operates in Trading. Ezak Pharma Private Limited reported revenue of ₹9 Lakh (FY 2025).

DIN 06506988
Primary Designation Director
Industry Trading
First Appointment 03 Apr 2013
Oldest Company Age 13 yrs
Largest company Ezak Pharma Private Limited · ₹9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ezak Pharma Private Limited U51397DL2013PTC250207
Director03 Apr 20132013₹9 Lakh (FY 2025)Active

Board colleagues of Guncha Tabasum

NameDINCompanyDesignation
Furquan Ahmad Azad06506992Ezak Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ezak Pharma Private Limited
Premium access

Shareholding and investment profile for Guncha Tabasum

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Guncha Tabasum

Guncha Tabasum currently holds 1 directorship: Ezak Pharma Private Limited (Director, since 03 Apr 2013, revenue ₹9 Lakh (FY 2025)).

Guncha Tabasum was first appointed on 03 Apr 2013 as Director at Ezak Pharma Private Limited.

The current boards of Guncha Tabasum's companies include Furquan Ahmad Azad (Ezak Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available